184 related articles for article (PubMed ID: 22507966)
1. Radiotherapy in parotid acinic cell carcinoma: does it have an impact on survival?
Andreoli MT; Andreoli SM; Shrime MG; Devaiah AK
Arch Otolaryngol Head Neck Surg; 2012 May; 138(5):463-6. PubMed ID: 22507966
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes and quality of life of 186 patients with primary parotid carcinoma treated with surgery and radiotherapy at the Daniel den Hoed Cancer Center.
Al-Mamgani A; van Rooij P; Verduijn GM; Meeuwis CA; Levendag PC
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):189-95. PubMed ID: 22330990
[TBL] [Abstract][Full Text] [Related]
3. Clinical prognostic factors in malignant parotid gland tumors.
Lima RA; Tavares MR; Dias FL; Kligerman J; Nascimento MF; Barbosa MM; Cernea CR; Soares JR; Santos IC; Salviano S
Otolaryngol Head Neck Surg; 2005 Nov; 133(5):702-8. PubMed ID: 16274796
[TBL] [Abstract][Full Text] [Related]
4. Analysis of acinic cell carcinoma of the parotid gland - 15 years experience.
Lin WN; Huang HC; Wu CC; Liao CT; Chen IH; Kan CJ; Huang SF
Acta Otolaryngol; 2010 Dec; 130(12):1406-10. PubMed ID: 20809887
[TBL] [Abstract][Full Text] [Related]
5. Close Margins and Adjuvant Radiotherapy in Acinic Cell Carcinoma of the Parotid Gland.
Zenga J; Parikh AS; Emerick KS; Lin DT; Faquin WC; Deschler DG
JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1011-1016. PubMed ID: 29978180
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant radiation therapy for high-grade and/or locally advanced major salivary gland tumors.
Mahmood U; Koshy M; Goloubeva O; Suntharalingam M
Arch Otolaryngol Head Neck Surg; 2011 Oct; 137(10):1025-30. PubMed ID: 22006781
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
[TBL] [Abstract][Full Text] [Related]
8. Parotid gland lymphoma: prognostic analysis of 2140 patients.
Feinstein AJ; Ciarleglio MM; Cong X; Otremba MD; Judson BL
Laryngoscope; 2013 May; 123(5):1199-203. PubMed ID: 23576299
[TBL] [Abstract][Full Text] [Related]
9. Descriptive nomograms of adjuvant radiotherapy use and patterns of care analysis for stage I and II endometrial adenocarcinoma: A surveillance, epidemiology, and end results population study.
Lee CM; Szabo A; Shrieve DC; Macdonald OK; Tward JD; Skidmore TB; Gaffney DK
Cancer; 2007 Nov; 110(9):2092-100. PubMed ID: 17849468
[TBL] [Abstract][Full Text] [Related]
10. Treatment of carcinoma of the parotid gland: the results of a multicenter study.
Tullio A; Marchetti C; Sesenna E; Brusati R; Cocchi R; Eusebi V
J Oral Maxillofac Surg; 2001 Mar; 59(3):263-70. PubMed ID: 11243607
[TBL] [Abstract][Full Text] [Related]
11. Malignant parotid tumors: presentation, clinical/pathologic prognostic factors, and treatment outcomes.
Pohar S; Gay H; Rosenbaum P; Klish D; Bogart J; Sagerman R; Hsu J; Kellman R
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):112-8. PubMed ID: 15629601
[TBL] [Abstract][Full Text] [Related]
12. Mucoepidermoid carcinoma of the parotid gland: the Mayo clinic experience.
Boahene DK; Olsen KD; Lewis JE; Pinheiro AD; Pankratz VS; Bagniewski SM
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):849-56. PubMed ID: 15262762
[TBL] [Abstract][Full Text] [Related]
13. Survival in oral cavity minor salivary gland carcinoma.
Kakarala K; Bhattacharyya N
Otolaryngol Head Neck Surg; 2010 Jul; 143(1):122-6. PubMed ID: 20620630
[TBL] [Abstract][Full Text] [Related]
14. Oncologic benefit of tonsillectomy in stage I and II tonsil cancer: a surveillance epidemiology and end results database review.
Holliday MA; Tavaluc R; Zhuang T; Wang H; Davidson B
JAMA Otolaryngol Head Neck Surg; 2013 Apr; 139(4):362-6. PubMed ID: 23599071
[TBL] [Abstract][Full Text] [Related]
15. Malignant parotid tumors in 110 consecutive patients: treatment results and prognosis.
Pedersen D; Overgaard J; Søgaard H; Elbrønd O; Overgaard M
Laryngoscope; 1992 Sep; 102(9):1064-9. PubMed ID: 1518354
[TBL] [Abstract][Full Text] [Related]
16. Surgery and radiotherapy for retroperitoneal and abdominal sarcoma: both necessary and sufficient.
Zhou Z; McDade TP; Simons JP; Ng SC; Lambert LA; Whalen GF; Shah SA; Tseng JF
Arch Surg; 2010 May; 145(5):426-31. PubMed ID: 20479339
[TBL] [Abstract][Full Text] [Related]
17. 672 patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma.
Wisnoski NC; Townsend CM; Nealon WH; Freeman JL; Riall TS
Surgery; 2008 Aug; 144(2):141-8. PubMed ID: 18656619
[TBL] [Abstract][Full Text] [Related]
18. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
19. Extent of parotid disease influences outcome in patients with metastatic cutaneous squamous cell carcinoma.
Palme CE; O'Brien CJ; Veness MJ; McNeil EB; Bron LP; Morgan GJ
Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):750-3. PubMed ID: 12874077
[TBL] [Abstract][Full Text] [Related]
20. Outcomes and prognostic factors for parotid acinic cell Carcinoma: A National Cancer Database study of 2362 cases.
Scherl C; Kato MG; Erkul E; Graboyes EM; Nguyen SA; Chi AC; Morgan PF; Day TA
Oral Oncol; 2018 Jul; 82():53-60. PubMed ID: 29909902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
